The New England Journal of Medicine
e-mail icon  FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |    Advanced Search
Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe
 
Correspondence
PreviousPrevious
Volume 335:1845-1846 December 12, 1996 Number 24
NextNext

Bone Marrow Transplantation for Sickle Cell Disease

Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

 Sign up for free e-toc
 

This Article
-Full Text
-Purchase this article

Tools and Services
-Add to Personal Archive
-Add to Citation Manager
-Notify a Friend
-E-mail When Cited

More Information
-Related Article
 by Walters, M. C.
-PubMed Citation
To the Editor: The report by Walters et al. on successful eradication of sickle cell disease through bone marrow transplantation (Aug. 8 issue)1 raises some ethical issues. Although this multicenter study was conducted under the supervision of a Data Safety and Monitoring Board of the National Institutes of Health and had the approval of each center's institutional review board, the article raises questions about the issues of informed consent. The following statement from the methods section is confusing: "All the patients or their parents or guardians gave written informed consent for their participation." The study involved only children under 16 . . . [Full Text of this Article]

References




HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org

Comments and questions? Please contact us.

The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.